As Valeant Pharmaceuticals Intl Inc (NYSE:VRX) continues to face legal battles on several fronts and Relypsa Inc (NASDAQ:RLYP) struggles to ramp sales of …
Analysts weigh in on drug makers Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Synergy Pharmaceuticals Inc (NASDAQ:SGYP), and EXACT Sciences Corporation (NASDAQ:EXAS). While Valeant just hosted an investor …
The ups and downs of biotech companies cease to abate as analysts weigh in on Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Celgene Corporation (NASDAQ:CELG), …
Analysts weigh in on biotech companies Celgene Corporation (NASDAQ:CELG) and Relypsa Inc (NASDAQ:RLYP). While one analyst is bullish on Celgene ahead of earnings, …
Analysts are not wasting a minute as they are eager to weigh in on beaten biotech stocks Clovis Oncology Inc (NASDAQ:CLVS) and Horizon Pharma PLC …
Most popular company Apple Inc (NASDAQ:AAPL) is expected to report second-quarter earnings shortly, while security company Palo Alto Networks (NYSE:PANW) experienced positive outcomes …
Healthcare analysts were out with research notes on pain drug maker Depomed Inc (NASDAQ:DEPO) and biopharmaceutical giant Celgene Corporation (NASDAQ:CELG). While activist investment firm Starboard Value disclosed a 9.
Analysts weigh in on two biotech giants as one, Valeant Pharmaceuticals Intl Inc (NYSE:VRX), tries to dig itself out of a hole of debt …
Healthcare analysts from Mizuho and Maxim weigh in on pharma giant Allergan plc Ordinary Shares (NYSE:AGN) and cell therapy firm Cytori Therapeutics Inc (NASDAQ:CYTX), following …
Mizuho analyst Irina Rivkind Koffler weighed in today on Mallinckrodt PLC (NYSE:MNK), after the pharmaceutical company entered into a purchase agreement with The Medicines Company to …
